Dr. Reddy's Laboratories Limited (DRREDDY.NS)
INR 1182.9
(-0.08%)
INR 1182.9
(-0.08%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 163.6 Billion INR | -3.36% |
| 2022 | 169.3 Billion INR | 48.72% |
| 2021 | 113.84 Billion INR | 10.44% |
| 2020 | 103.07 Billion INR | 9.65% |
| 2019 | 94 Billion INR | 12.68% |
| 2018 | 83.43 Billion INR | 9.34% |
| 2017 | 76.3 Billion INR | -2.62% |
| 2016 | 78.35 Billion INR | -15.09% |
| 2015 | 92.28 Billion INR | 8.05% |
| 2014 | 85.4 Billion INR | 12.67% |
| 2013 | 75.8 Billion INR | 25.13% |
| 2012 | 60.57 Billion INR | 13.65% |
| 2011 | 53.3 Billion INR | 32.39% |
| 2010 | 40.26 Billion INR | 10.8% |
| 2009 | 36.34 Billion INR | -0.44% |
| 2008 | 36.5 Billion INR | 43.66% |
| 2007 | 25.4 Billion INR | -17.9% |
| 2006 | 30.94 Billion INR | 160.51% |
| 2005 | 11.88 Billion INR | 17.79% |
| 2004 | 10.08 Billion INR | -6.25% |
| 2003 | 10.75 Billion INR | 5.46% |
| 2002 | 10.2 Billion INR | 4.71% |
| 2001 | 9.74 Billion INR | 86.65% |
| 2000 | 5.22 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 44.22 Billion INR | 6.61% |
| 2024 Q2 | 46.86 Billion INR | 3.06% |
| 2023 Q4 | 41.48 Billion INR | -1.71% |
| 2023 Q2 | 40.36 Billion INR | 2.06% |
| 2023 Q1 | 39.55 Billion INR | -23.43% |
| 2023 Q3 | 42.2 Billion INR | 4.55% |
| 2023 FY | 163.6 Billion INR | -3.36% |
| 2022 Q1 | 26 Billion INR | -9.52% |
| 2022 FY | 169.3 Billion INR | 48.72% |
| 2022 Q4 | 51.65 Billion INR | 28.84% |
| 2022 Q3 | 40.09 Billion INR | 7.64% |
| 2022 Q2 | 37.24 Billion INR | 43.22% |
| 2021 Q1 | 25.69 Billion INR | 1.28% |
| 2021 Q2 | 30.78 Billion INR | 19.79% |
| 2021 FY | 113.84 Billion INR | 10.44% |
| 2021 Q3 | 28.61 Billion INR | -7.06% |
| 2021 Q4 | 28.74 Billion INR | 0.46% |
| 2020 Q2 | 26.4 Billion INR | 6.68% |
| 2020 Q4 | 25.37 Billion INR | -4.38% |
| 2020 FY | 103.07 Billion INR | 9.65% |
| 2020 Q3 | 26.53 Billion INR | 0.49% |
| 2020 Q1 | 24.75 Billion INR | 8.54% |
| 2019 Q4 | 22.8 Billion INR | -3.85% |
| 2019 FY | 94 Billion INR | 12.68% |
| 2019 Q3 | 23.72 Billion INR | -14.11% |
| 2019 Q1 | 19.85 Billion INR | -5.67% |
| 2019 Q2 | 27.62 Billion INR | 39.08% |
| 2018 Q4 | 21.05 Billion INR | 1.45% |
| 2018 FY | 83.43 Billion INR | 9.34% |
| 2018 Q1 | 20.72 Billion INR | 9.7% |
| 2018 Q2 | 20.89 Billion INR | 0.82% |
| 2018 Q3 | 20.75 Billion INR | -0.69% |
| 2017 FY | 76.3 Billion INR | -2.62% |
| 2017 Q4 | 18.89 Billion INR | -11.75% |
| 2017 Q3 | 21.41 Billion INR | 13.28% |
| 2017 Q2 | 18.9 Billion INR | 10.55% |
| 2017 Q1 | 17.09 Billion INR | -5.97% |
| 2016 Q3 | 21.89 Billion INR | 8.97% |
| 2016 Q2 | 20.09 Billion INR | 10.56% |
| 2016 FY | 78.35 Billion INR | -15.09% |
| 2016 Q1 | 18.17 Billion INR | -14.56% |
| 2016 Q4 | 18.18 Billion INR | -16.97% |
| 2015 Q3 | 23.59 Billion INR | -3.59% |
| 2015 Q4 | 21.27 Billion INR | -9.81% |
| 2015 Q1 | 22.94 Billion INR | 8.13% |
| 2015 Q2 | 24.46 Billion INR | 6.63% |
| 2015 FY | 92.28 Billion INR | 8.05% |
| 2014 Q1 | 20.84 Billion INR | 4.63% |
| 2014 FY | 85.4 Billion INR | 12.67% |
| 2014 Q4 | 21.22 Billion INR | -5.06% |
| 2014 Q3 | 22.35 Billion INR | 6.51% |
| 2014 Q2 | 20.98 Billion INR | 0.68% |
| 2013 FY | 75.8 Billion INR | 25.13% |
| 2013 Q3 | 21.39 Billion INR | 9.87% |
| 2013 Q2 | 19.46 Billion INR | 29.63% |
| 2013 Q1 | 15.01 Billion INR | -10.85% |
| 2013 Q4 | 19.92 Billion INR | -6.87% |
| 2012 Q1 | 13.54 Billion INR | -3.08% |
| 2012 Q2 | 15.3 Billion INR | 13.03% |
| 2012 Q3 | 15.09 Billion INR | -1.4% |
| 2012 Q4 | 16.84 Billion INR | 11.63% |
| 2012 FY | 60.57 Billion INR | 13.65% |
| 2011 Q1 | 10.55 Billion INR | -3.6% |
| 2011 FY | 53.3 Billion INR | 32.39% |
| 2011 Q2 | 12.2 Billion INR | 15.63% |
| 2011 Q3 | 16.57 Billion INR | 35.8% |
| 2011 Q4 | 13.97 Billion INR | -15.71% |
| 2010 FY | 40.26 Billion INR | 10.8% |
| 2010 Q4 | 10.94 Billion INR | 5.14% |
| 2010 Q3 | 10.41 Billion INR | 4.29% |
| 2010 Q2 | 9.98 Billion INR | 12.03% |
| 2010 Q1 | 8.91 Billion INR | 3.2% |
| 2009 Q1 | 10.17 Billion INR | -5.54% |
| 2009 FY | 36.34 Billion INR | -0.44% |
| 2009 Q4 | 8.63 Billion INR | -1.94% |
| 2009 Q3 | 8.8 Billion INR | 1.03% |
| 2009 Q2 | 8.71 Billion INR | -14.28% |
| 2008 Q3 | 10.27 Billion INR | 28.99% |
| 2008 Q4 | 10.76 Billion INR | 4.84% |
| 2008 Q2 | 7.96 Billion INR | 5.3% |
| 2008 Q1 | 7.56 Billion INR | 7.94% |
| 2008 FY | 36.5 Billion INR | 43.66% |
| 2007 Q1 | 6.08 Billion INR | -37.78% |
| 2007 Q4 | 7 Billion INR | 16.0% |
| 2007 Q3 | 6.03 Billion INR | -2.01% |
| 2007 Q2 | 6.16 Billion INR | 1.37% |
| 2007 FY | 25.4 Billion INR | -17.9% |
| 2006 Q2 | 8.25 Billion INR | 35.42% |
| 2006 Q1 | 6.09 Billion INR | 108.23% |
| 2006 FY | 30.94 Billion INR | 160.51% |
| 2006 Q4 | 9.77 Billion INR | 44.54% |
| 2006 Q3 | 6.76 Billion INR | -18.14% |
| 2005 Q2 | 2.96 Billion INR | 1.43% |
| 2005 Q1 | 2.92 Billion INR | 9.76% |
| 2005 Q4 | 2.92 Billion INR | -2.83% |
| 2005 Q3 | 3.01 Billion INR | 1.64% |
| 2005 FY | 11.88 Billion INR | 17.79% |
| 2004 Q3 | 2.26 Billion INR | -23.6% |
| 2004 Q4 | 2.66 Billion INR | 17.52% |
| 2004 Q2 | 2.96 Billion INR | 13.04% |
| 2004 Q1 | 2.62 Billion INR | 4.5% |
| 2004 FY | 10.08 Billion INR | -6.25% |
| 2003 Q4 | 2.51 Billion INR | -6.08% |
| 2003 FY | 10.75 Billion INR | 5.46% |
| 2003 Q1 | 2.66 Billion INR | -0.7% |
| 2003 Q2 | 2.92 Billion INR | 10.02% |
| 2003 Q3 | 2.67 Billion INR | -8.7% |
| 2002 Q2 | 2.64 Billion INR | 5.14% |
| 2002 FY | 10.2 Billion INR | 4.71% |
| 2002 Q4 | 2.68 Billion INR | 12.92% |
| 2002 Q3 | 2.37 Billion INR | -10.21% |
| 2002 Q1 | 2.51 Billion INR | 10.84% |
| 2001 Q1 | 1.42 Billion INR | 0.0% |
| 2001 FY | 9.74 Billion INR | 86.65% |
| 2001 Q4 | 2.26 Billion INR | -17.59% |
| 2001 Q3 | 2.75 Billion INR | -16.49% |
| 2001 Q2 | 3.29 Billion INR | 130.78% |
| 2000 FY | 5.22 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | -8071.023% |
| Ind-Swift Limited | 2.17 Billion INR | -7430.71% |
| Innova Captab Limited | 3.46 Billion INR | -4622.466% |
| Aarti Drugs Limited | 8.31 Billion INR | -1867.329% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -2705.644% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -11016.071% |
| Sakar Healthcare Limited | 699.58 Million INR | -23286.293% |
| Aurobindo Pharma Limited | 109.54 Billion INR | -49.353% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 9980.246% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -2529.196% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -23570.234% |
| Morepen Laboratories Limited | 6.16 Billion INR | -2555.406% |
| Sequent Scientific Limited | 2.97 Billion INR | -5392.509% |
| Wanbury Limited | 1.73 Billion INR | -9353.538% |
| Laurus Labs Limited | 15.44 Billion INR | -959.034% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -3292.021% |
| Gufic Biosciences Limited | 4.07 Billion INR | -3916.144% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -1215.91% |
| Alembic Limited | 1 Billion INR | -16258.95% |
| Hikal Limited | 5.95 Billion INR | -2646.005% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -510.914% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | -135.947% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -3366.911% |
| Themis Medicare Limited | 2.42 Billion INR | -6660.6% |
| RPG Life Sciences Limited | 2.48 Billion INR | -6489.086% |
| Lupin Limited | 125.09 Billion INR | -30.786% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -7712.995% |
| Wockhardt Limited | 7.72 Billion INR | -2019.262% |
| Vaishali Pharma Limited | 90.32 Million INR | -181035.48% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -24970.412% |
| NATCO Pharma Limited | 25.73 Billion INR | -535.713% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -732.902% |
| FDC Limited | 6.58 Billion INR | -2384.084% |
| Divi's Laboratories Limited | 32.44 Billion INR | -404.337% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -26267.94% |
| Eris Lifesciences Limited | 10.42 Billion INR | -1469.102% |
| Windlas Biotech Limited | 1.33 Billion INR | -12120.421% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 36.706% |
| Mankind Pharma Limited | 42.19 Billion INR | -287.722% |
| Venus Remedies Limited | 2.18 Billion INR | -7396.02% |
| ZIM Laboratories Limited | 1.26 Billion INR | -12804.663% |
| Neuland Laboratories Limited | 8.24 Billion INR | -1883.635% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -972.206% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -8570.833% |
| Zydus Lifesciences Limited | 125.21 Billion INR | -30.665% |
| Bal Pharma Limited | 770.19 Million INR | -21142.283% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -30819.65% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -1677.081% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -4327.273% |
| Shilpa Medicare Limited | 3.56 Billion INR | -4493.255% |
| Orchid Pharma Limited | 2.32 Billion INR | -6951.105% |
| Albert David Limited | 1.4 Billion INR | -11519.097% |
| Ajanta Pharma Limited | 21.06 Billion INR | -676.714% |
| Hester Biosciences Limited | 1.27 Billion INR | -12745.523% |
| Valiant Laboratories Limited | 138.02 Million INR | -118430.888% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -3867.891% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -2729.885% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -144647.808% |
| Granules India Limited | 16.79 Billion INR | -873.893% |
| Alkem Laboratories Limited | 52.29 Billion INR | -212.843% |
| Medicamen Biotech Limited | 495.49 Million INR | -32918.9% |
| Unichem Laboratories Limited | 4.86 Billion INR | -3262.987% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -36083.991% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -1304061.02% |
| Medico Remedies Limited | 262.14 Million INR | -62311.118% |
| Ipca Laboratories Limited | 48.58 Billion INR | -236.75% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -29141.488% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -3858.345% |
| Brooks Laboratories Limited | 65.62 Million INR | -249224.901% |
| Piramal Enterprises Limited | 8.04 Billion INR | -1934.078% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | -249.907% |
| Suven Life Sciences Limited | -200.79 Million INR | 81578.807% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 150547.369% |
| Strides Pharma Science Limited | 14.38 Billion INR | -1037.099% |
| Indoco Remedies Limited | 8.04 Billion INR | -1934.154% |
| Alpa Laboratories Limited | 188.89 Million INR | -86512.668% |
| Lasa Supergenerics Limited | 121.02 Million INR | -135078.882% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -41736.161% |